CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 46 enrolled
Drug / intervention
Pirinase Hayfever Relief for Adults 0.05% Nasal Spraydrug
Likely dose
Fluticasone propionate 50 micrograms per actuation (0.05% nasal spray)AI-extracted
Key inclusion· 4
  • ✓Participants who have purchased and used Pirinase Hayfever Relief for Adults 0.05% Nasal Spray for at least 7 days
  • ✓Willing to participate in online survey
  • ✓Any age
  • ✓Any gender
Key exclusion· 2
  • ✕Healthcare professionals (doctors, nurses, pharmacists)
  • ✕Decline to participate in online survey

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02856282
NCT02856282N/ACompleted
CompareCT.gov

Drug Utilization Study for Pirinase Hayfever Relief for Adults 0.05% Nasal Spray

GlaxoSmithKline·observational·Posted Aug 4, 2016·Updated Jun 24, 2019

In Brief

An observational study evaluating Pirinase Hayfever Relief for Adults 0.05% Nasal Spray for Rhinitis, Allergic, Seasonal. Completed, enrolled 46 participants across 1 site.

Detailed Summary

The purpose is to obtain real-world information on how consumers are complying with the product labelling This study will coincide with the launch of Pirinase Hayfever Relief for Adults 0.05% Nasal Spray in the United Kingdom (UK).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRhinitis, Allergic, Seasonal
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 4, 2016
Enrollment StartFeb 15, 2016
Primary CompletionMar 31, 2018
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 9.9 years ago

Interventions

Pirinase Hayfever Relief for Adults 0.05% Nasal Spraydrug

Aqueous suspension of 0.05% micronised fluticasone propionate.Each actuation contains 50 micrograms of fluticasone propionate